SLNO
SLNO
NASDAQ · Biotechnology

Soleno Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$53.01
+0.00 (+0.00%)
As of Jun 24, 1:25 PM ET ·
Analyst Consensus
Hold
16
Analysts
High
Coverage
Buy 0 0%
Hold 13 81%
Sell 3 19%
Price Target
Analyst Price Target -62.4% upside
Low Target $16.99
Average Target $19.95
High Target $27.29
Current Price $53.01
Current
$53.01
Target
$19.95
$16.99 $19.95 avg $27.29
Scenario Analysis
Bear Case
$16.99
-67.9%
Low target
Base Case
$19.95
-62.4%
Avg target
Bull Case
$27.29
+-48.5%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$90.32
-41.3% from high
52-Week Low
$29.43
+80.1% from low
50-Day SMA
$44.35
+19.5% vs SMA
200-Day SMA
$63.31
-16.3% vs SMA
RSI (14)
47.2
Neutral
Target vs 52W High
$19.95
-77.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%